TAG:
acla
MD Self-Referral Issues Target of Utilization Study
By Robert Michel | From the Volume XIX No. 6 – April 23, 2012 Issue
CEO SUMMARY: When it comes to the in-office ancillary service (IOAS) exception to physician self-referral, the issue of in-clinic pathology services has become a hot potato. Publication in Health Affairs of a study of urologists’ self-referral of their patients for anatomic pathology se…
Hospitals Get Bad News Re: TC Grandfather Expire
By Joseph Burns | From the Volume XIX No. 6 – April 23, 2012 Issue
CEO SUMMARY: During negotiations to extend the payroll tax cut in February, Congressional negotiators agreed to end the technical component (TC) grandfather provision for more than 1,000 rural hospitals. Seeking to save $50 million annually, Congress said anatomic pathologists would no lo…
Shaw & Adelman Successful Support of Lab Networks Need Hospital Leadership
By Joseph Burns | From the Volume XIX No. 3 – February 20, 2012 Issue
CEO Summary: In the second installment of our exclusive two- part interview, the executive directors of two regional laboratory networks formed in the 1990s (one in Michigan and one in Washington State) share their assessment of why their respective lab networks have performed strongly ov…
From Modest Beginnings, Two Lab Networks Find Success
By Robert Michel | From the Volume XIX No. 2 – January 30, 2012 Issue
“For 20 years, our regional laboratory network here in Detroit has played an important role in helping member …
ACLA Has its Say Regarding Molecular Dx Proposals
By Robert Michel | From the Volume XVIII No. 17 – December 19, 2011 Issue
CEO SUMMARY: It is not known how many public comments have been submitted to Palmetto GBA, the big Medicare carrier, in response to its published proposals to change how code stacked claims for genetic and molecular tests will be handled, effective February 27, 2012, for labs in Medicare …
Congress Likely to Pass Deep Cuts in Lab Test Fees
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
CEO SUMMARY: All signs point to a potentially dismal financial outcome for the clinical lab testing industry as Congress tries to trim spending by $1.2 trillion over the next 10 years. At least three proposals to significantly cut lab test reimbursement are in active debate by fe…
September 26, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 13 – September 26, 2011 Issue
Here’s a laboratory with what may be one of the world’s biggest accounts receivable problems. In South Africa, the National Health Laboratory Services (NHLS) says it is owed $1.8 billion Rand (about US $214 million) from its client accounts. As reported by a regional television s…
September 6, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 12 – September 6, 2011 Issue
Cleveland Heart Lab closed on a Series B financing round that totals $18.4 million. The money was provided by Excel Venture Management, Healthcare Ventures, and existing investors. Executives at Cleve- land Heart Lab said the new funds will be used t…
Congress Again Considers Co-Insurance for Lab Tests
By Robert Michel | From the Volume XXVIII No. 11 – August 15, 2011 Issue
CEO SUMMARY: Congressional cost-cutters are putting the 20% patient co-pay/coinsurance requirement for lab testing back on the table. The added complication this year is that the new Joint Select Committee on Deficit Reduction is mandated to produce its own list of cuts to the Me…
July 25, 2011 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVIII No. 10 – July 25, 2011 Issue
In a play to expand its presence in cervical cancer testing, Roche Holdings announced an agreement to acquire mtm laboratories AG, based in Heidelberg, Germany. Roche will pay U.S. $180 million, plus another U.S. $85 million if performance milestones are achieved. mt…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized